• Anti-TG6 ELISAs reloaded!
    Gluten-sensitive neurological disorders like Gluten ataxia may be accompanied by auto- antibodies to neuronal transglutaminase (TG6).

    Detection of TG6-autoantibodies in human sera is possible using our ELISA-Kits E103 (anti-TG6-IgA) and E104 (anti-TG6-IgG).

    New: Analytical service for measurement of TG6-autoantibodies in human serum samples
  • Novel DD-XLink-mab available!
    Zedira scientists developed a monoclonal antibody which directly recognizes the crosslinked fibrin neoepitope (DD-XLink-mab, A076).

    Find more information about this novel antibody by clicking here!
  • TGase Protein Labeling Kits
    Site specific labeling of proteins catalyzed by transglutaminase:

    TGase Labeling

    Substrate Finder Kit enables you to characterize your target proteins transglutaminase substrate properties and to chose the appropriate labeling kit.

    Zedira offers kits for labeling with: Biotin, PEG1,088, PEG5,000,
    ATTO-488TM, ATTO-532TM, ATTO-550TM, ATTO-647NTM and ATTO-700TM.
  • News  

    • Press release: Dr. Falk Pharma and Zedira announce completion of phase 1b clinical trial of ZED1227 for the treatment of celiac disease and move on to proof of concept study
    • Pressemitteilung: Dr. Falk Pharma und Zedira geben den Abschluss der Phase 1b-Studie für ZED1227 zur Zöliakie-Therapie bekannt und planen Start der Wirksamkeitsstudie
  • Blog

  • Events  

    • Transglutaminases in Medicine

      03.08.2017 - 05.08.2017
      Debrecen, Hungary

    • 17th International Celiac Disease Symposium

      08.09.2017 - 10.09.2017
      New Delhi, India

    • NLSDays 2017

      12.09.2017 - 14.09.2017
      Malmö, Sweden

    • BIO-Europe

      06.11.2017 - 08.11.2017
      Berlin, Germany

    • MEDICA

      13.11.2017 - 16.11.2017
      Düsseldorf, Germany

    • Gordon Research Conference on: Transglutaminases in Human Disease Processes

      16.06.2018 - 17.06.2018
      Les Diablerets, Switzerland